ArticleAdvances in rheumatology (London, England)2023

Baricitinib improves pulmonary fibrosis in mice with rheumatoid arthritis-associated interstitial lung disease by inhibiting the Jak2/Stat3 signaling pathway.

Hongli Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.